Clinical Trial News and Research

RSS

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide.

14 Jul 2022

Virtual reality app trial offers new hope for people suffering from phobias

Results from a University of Otago, Christchurch trial suggest fresh hope for the estimated one-in-twelve people worldwide suffering from a fear of flying, needles, heights, spiders and dogs.

14 Jul 2022

NCRI CTRad publishes strategic priorities in radiotherapy research to improve patient outcomes

The NCRI Radiotherapy (CTRad) Group, a world-leading radiotherapy research group, has published its strategic priorities in radiotherapy research to address challenges in the field.

14 Jul 2022

Study finds the cause behind women experiencing higher rates of depression than men

Although treatments for depression exist, sometimes these treatments don't work for many who use them. Furthermore, women experience higher rates of depression than men, yet the cause for this difference is unknown, making their illnesses, at times, more complicated to treat.

14 Jul 2022

Geisinger researchers receive two grants to study risk factors linked with familial hypercholesterolemia

Geisinger researchers have been awarded two grants from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to study risk factors associated with familial hypercholesterolemia (FH) and ways to improve screening, diagnosis and communication with patients.

13 Jul 2022

Knowledge gaps in product labels make it challenging for healthcare providers to recommend vaccines to pregnant women

Existing gaps and serious limitations concerning the information in vaccine product labels makes it challenging for healthcare providers to know when to recommend vaccination to pregnant women.

13 Jul 2022

New noninvasive method could allow screening for hypertension-linked aldosterone adenomas

Researchers have developed a noninvasive method to identify a potential cause of hypertension with a drastic reduction in radiation exposure, a study shows.

13 Jul 2022

Study evaluates the effectiveness of universal school-based mindfulness training

School-based mindfulness training, universally applied across the UK in a bid to boost teen mental health and wellbeing, probably isn't warranted, suggest the results of a cluster of 5 studies, published online in a special issue of Evidence-Based Mental Health.

13 Jul 2022

Long covid patients travel abroad seeking for unproven "blood-washing" treatment

Thousands of people experiencing the debilitating symptoms of long covid are traveling abroad to seek costly but unproven treatments such as "blood washing", according to an investigation carried out by The BMJ and ITV News released today.

13 Jul 2022

Psilocybin microdosing associated with mood and mental health improvements

The latest study to examine how tiny amounts of psychedelics can impact mental health provides further evidence of the therapeutic potential of microdosing.

11 Jul 2022

Nuclear stress testing can help shape physicians' decision to refer patients for heart procedures

Patients identified by nuclear stress testing as having severe stress-induced myocardial ischemia (lack of blood flow to the heart) are likely to benefit from heart bypass surgery or angioplasty, while those with mild or no ischemia are not, according to a new study from the Icahn School of Medicine at Mount Sinai.

11 Jul 2022

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an investigational vaccine to prevent infection with Nipah virus.

11 Jul 2022

Artificial Intelligence-based smartphone app for characterizing stool form

In a recent study published in the American Journal of Gastroenterology, researchers at Cedars-Sinai Medical Center in the United States evaluated an artificial intelligence (AI)-based smartphone application (app) trained to assess a patient's stool characteristics.

10 Jul 2022

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.

8 Jul 2022

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung cancer (SCLC) recently reached the trial's accrual goal of 506 patients.

8 Jul 2022

Novel COVID-19 antibody delivery approach advances to clinical trials

Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery approach has advanced to clinical trials.

7 Jul 2022

Low doses of a less commonly used drug may be a better treatment option for gout

Gout occurs when urate crystals accumulate in the joints, and xanthine oxidase inhibitors such as febuxostat are a mainstay of therapy to help reduce blood urate levels in affected patients.

7 Jul 2022

Novel gene-based therapies for sickle cell disease rely on finding the right mouse for the job

Sickle cell disease is an extremely debilitating condition that affects up to 40% of the population in African countries, with patients suffering episodes of excruciating pain, organ damage and reduced life-expectancy.

7 Jul 2022

Researchers find a way to kill recurring prostate cancer with a lot of iron

Prostate cancer can come back from common hormone deprivation therapy with a vengeance and no clear treatment option, but scientists have early evidence that one way to kill these recurring cancer cells may be with a lot of iron.

7 Jul 2022

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

DZNE and Intravacc B.V., a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, have been awarded a funding of € 2.5 million from the European Union (EIC Transition Grant) to further develop a prototype ALS vaccine, including process development, scale-up, and toxicology study.

6 Jul 2022

Clinical Trial News and Research

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Virtual reality app trial offers new hope for people suffering from phobias

NCRI CTRad publishes strategic priorities in radiotherapy research to improve patient outcomes

Study finds the cause behind women experiencing higher rates of depression than men

Geisinger researchers receive two grants to study risk factors linked with familial hypercholesterolemia

Knowledge gaps in product labels make it challenging for healthcare providers to recommend vaccines to pregnant women

New noninvasive method could allow screening for hypertension-linked aldosterone adenomas

Study evaluates the effectiveness of universal school-based mindfulness training

Long covid patients travel abroad seeking for unproven "blood-washing" treatment

Psilocybin microdosing associated with mood and mental health improvements

Nuclear stress testing can help shape physicians' decision to refer patients for heart procedures

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

Artificial Intelligence-based smartphone app for characterizing stool form

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

Novel COVID-19 antibody delivery approach advances to clinical trials

Low doses of a less commonly used drug may be a better treatment option for gout

Novel gene-based therapies for sickle cell disease rely on finding the right mouse for the job

Researchers find a way to kill recurring prostate cancer with a lot of iron

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer